Cargando…

COVID 19 infection and mucormycosis—a dangerously increasing combination

Detalles Bibliográficos
Autores principales:	Bakshi, Satvinder Singh, Kalidoss, Vinoth Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159069/ http://dx.doi.org/10.1186/s43163-021-00121-w

Ejemplares similares

Is there an association between hypothyroidism and COVID 19?: A preliminary report
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

COVID-19 and smoking: an association requiring urgent attention
por: Kumar Kalidoss, Vinoth, et al.
Publicado: (2020)

Patient concern inventory: an effective tool for easing telemedicine during the COVID-19 pandemic
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

A Need to Estimate the Economic Burden of Oral Cancer in India
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

The Benefit of YouTube Videos as a Source of Information on Tinnitus for Patients
por: Bakshi, Satvinder Singh, et al.
Publicado: (2023)

A Cross-Sectional Study on the Effect of Chronic Noise Exposure on the Vestibular Function of Traffic Policemen and Automobile Drivers
por: Das, Soumyajit, et al.
Publicado: (2022)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Oral manifestations associated with COVID-19 disease: An observational cross sectional study()
por: Chawla, Jitendra, et al.
Publicado: (2022)

Rhino-orbital Mucormycosis
por: Bakshi, Satvinder Singh
Publicado: (2019)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)

Letter to the Editor()
por: Bakshi, Satvinder Singh
Publicado: (2015)

A toddler infected with mucormycosis – reporting the youngest case of mucormycosis in post COVID phase
por: Kubre, Jyotsna, et al.
Publicado: (2023)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

COVID-19 and its danger of distraction
por: Pothiawala, Sohil
Publicado: (2020)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope
por: Jadaun, Shekhar Singh, et al.
Publicado: (2021)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?
por: Kumar, Amarjeet, et al.
Publicado: (2022)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023)

Misuse of sibutramine and bulimia nervosa: a dangerous combination
por: Ferreira, Gabriela Mourão, et al.
Publicado: (2018)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

Danger of major outbreaks of COVID-19 in the Peruvian prison population
por: Enoki-Miñano, E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dr6aauqu7pqupjmhudns98el2u